Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study)

NCT03570281 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Correction of Cancer-related Coagulopathy With Novel Oral Anticoagulant (Edoxaban)

Interventions

DRUG: Edoxaban
DRUG: Enoxaparin

Sponsor

Samsung Medical Center